Narvaiza Iñigo, Linfesty Daniel C, Greener Benjamin N, Hakata Yoshiyuki, Pintel David J, Logue Eric, Landau Nathaniel R, Weitzman Matthew D
Laboratory of Genetics, The Salk Institute for Biological Studies, La Jolla, California, USA.
PLoS Pathog. 2009 May;5(5):e1000439. doi: 10.1371/journal.ppat.1000439. Epub 2009 May 22.
The APOBEC3 proteins form a multigene family of cytidine deaminases with inhibitory activity against viruses and retrotransposons. In contrast to APOBEC3G (A3G), APOBEC3A (A3A) has no effect on lentiviruses but dramatically inhibits replication of the parvovirus adeno-associated virus (AAV). To study the contribution of deaminase activity to the antiviral activity of A3A, we performed a comprehensive mutational analysis of A3A. By mutation of non-conserved residues, we found that regions outside of the catalytic active site contribute to both deaminase and antiviral activities. Using A3A point mutants and A3A/A3G chimeras, we show that deaminase activity is not required for inhibition of recombinant AAV production. We also found that deaminase-deficient A3A mutants block replication of both wild-type AAV and the autonomous parvovirus minute virus of mice (MVM). In addition, we identify specific residues of A3A that confer activity against AAV when substituted into A3G. In summary, our results demonstrate that deaminase activity is not necessary for the antiviral activity of A3A against parvoviruses.
载脂蛋白B mRNA编辑酶催化多肽样蛋白3(APOBEC3)蛋白形成一个胞苷脱氨酶多基因家族,对病毒和逆转录转座子具有抑制活性。与载脂蛋白B mRNA编辑酶催化多肽样蛋白3G(APOBEC3G,A3G)不同,载脂蛋白B mRNA编辑酶催化多肽样蛋白3A(APOBEC3A,A3A)对慢病毒没有影响,但能显著抑制细小病毒腺相关病毒(AAV)的复制。为了研究脱氨酶活性对A3A抗病毒活性的贡献,我们对A3A进行了全面的突变分析。通过非保守残基的突变,我们发现催化活性位点以外的区域对脱氨酶和抗病毒活性都有贡献。使用A3A点突变体和A3A/A3G嵌合体,我们表明抑制重组AAV产生不需要脱氨酶活性。我们还发现脱氨酶缺陷的A3A突变体可阻断野生型AAV和小鼠自主细小病毒微小病毒(MVM)的复制。此外,我们确定了A3A的特定残基,当将其替换到A3G中时可赋予对AAV的活性。总之,我们的结果表明脱氨酶活性对于A3A抗细小病毒的抗病毒活性不是必需的。